BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2124094)

  • 1. Sensitivity of in vivo X-ray fluorescence determination of skeletal lead stores.
    Sokas RK; Besarab A; McDiarmid MA; Shapiro IM; Bloch P
    Arch Environ Health; 1990; 45(5):268-72. PubMed ID: 2124094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removing lead from bone: clinical implications of bone lead stores.
    Wedeen RP
    Neurotoxicology; 1992; 13(4):843-52. PubMed ID: 1302310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of in vivo tibial K-XRF for monitoring lead stores.
    Wedeen RP; Ty A; Udasin I; Favata EA; Jones KW
    Arch Environ Health; 1995; 50(5):355-61. PubMed ID: 7574889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing bone lead content by chelation treatment in chronic lead poisoning: an in vivo X-ray fluorescence and bone biopsy study.
    Batuman V; Wedeen RP; Bogden JD; Balestra DJ; Jones K; Schidlovsky G
    Environ Res; 1989 Feb; 48(1):70-5. PubMed ID: 2492468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of L-line X-ray fluorescence to estimate bone lead values in lead-poisoned young children and in children, teenagers, and adults from lead-exposed and non-lead-exposed suburban communities in the United States.
    Rosen JF
    Toxicol Ind Health; 1997; 13(2-3):211-8. PubMed ID: 9200789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between bone lead and hemoglobin.
    Hu H; Watanabe H; Payton M; Korrick S; Rotnitzky A
    JAMA; 1994 Nov; 272(19):1512-7. PubMed ID: 7966843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.
    Rosen JF; Markowitz ME; Bijur PE; Jenks ST; Wielopolski L; Kalef-Ezra JA; Slatkin DN
    Environ Health Perspect; 1991 Feb; 91():57-62. PubMed ID: 1904023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.
    Rosen JF; Markowitz ME; Bijur PE; Jenks ST; Wielopolski L; Kalef-Ezra JA; Slatkin DN
    Environ Health Perspect; 1991 Jun; 93():271-7. PubMed ID: 1773798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of lead poisoning.
    Wynchank S; Selby P; Ehrlich R; Todd AC
    Presse Med; 1994 Nov; 23(36):1670. PubMed ID: 7899297
    [No Abstract]   [Full Text] [Related]  

  • 10. XRF-measured bone lead (Pb) as a biomarker for Pb exposure and toxicity among children diagnosed with Pb poisoning.
    Specht AJ; Lin Y; Weisskopf M; Yan C; Hu H; Xu J; Nie LH
    Biomarkers; 2016; 21(4):347-52. PubMed ID: 26856822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An upgraded 109Cd K X-ray fluorescence bone Pb measurement.
    Gordon CL; Chettle DR; Webber CE
    Basic Life Sci; 1993; 60():285-8. PubMed ID: 8110129
    [No Abstract]   [Full Text] [Related]  

  • 12. "Severe chronic lead insult that maintains body burdens of lead related to those in the skeleton": observations by Dr. Clair Patterson conclusively demonstrated.
    Rosen JF; Pounds JG
    Environ Res; 1998 Aug; 78(2):140-51. PubMed ID: 9719618
    [No Abstract]   [Full Text] [Related]  

  • 13. L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: public health implications.
    Rosen JF; Markowitz ME; Bijur PE; Jenks ST; Wielopolski L; Kalef-Ezra JA; Slatkin DN
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):685-9. PubMed ID: 2492111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lead nephropathy in Queensland: alternative methods of diagnosis.
    Craswell PW; Price J; Boyle PD; Heazlewood VJ; Baddeley H; Lloyd HM; Thomas BJ; Thomas BW; Williams GM
    Aust N Z J Med; 1986 Feb; 16(1):11-9. PubMed ID: 3085647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo x-ray fluorescence measurements of cadmium and lead.
    Nilsson U; Skerfving S
    Scand J Work Environ Health; 1993; 19 Suppl 1():54-8. PubMed ID: 8159974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 4 x 500 mm2 cloverleaf detector system for in vivo bone lead measurement.
    Fleming DE; Mills CE
    Med Phys; 2007 Mar; 34(3):945-51. PubMed ID: 17441240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vivo determination of lead in the skeleton after occupational exposure to lead.
    Ahlgren L; Haeger-Aronsen B; Mattsson S; Schütz A
    Br J Ind Med; 1980 May; 37(2):109-13. PubMed ID: 7426460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of a portable X-ray fluorescence device for bone lead measurements of condor bones.
    Specht AJ; Parish CN; Wallens EK; Watson RT; Nie LH; Weisskopf MG
    Sci Total Environ; 2018 Feb; 615():398-403. PubMed ID: 28988075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of covariance between the K alpha and the K beta lead peak concentrations on the uncertainty in the result of in vivo (109)Cd KXRF bone lead measurement.
    Brito JA
    Phys Med Biol; 2006 Dec; 51(23):6125-39. PubMed ID: 17110775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-invasive determination of bone lead in human body using X-ray fluorescence excited by 109Cd].
    Huang SB; Tian L; Cheng HS; Pei P
    Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Nov; 24(11):1470-2. PubMed ID: 15762508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.